Emerging Trends to Drive Cell Therapy Market Growth at 14.2% CAGR Through 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Cell Therapy Market Size Growth Forecast: What to Expect by 2025?
The market size for cell therapy has seen a fast-paced expansion in the recent past. It is projected to increase from a valuation of $14.56 billion in 2024 to $16.87 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.8%. The growth experienced during the historic period can be credited to early research and findings, achievement of regulatory milestones, clinical trials and studies, innovative companies and early adopters, along with generally favorable market acceptance and perception.

How Will the Cell Therapy Market Size Evolve and Grow by 2029?
In the next few years, the cell therapy market size is predicted to experience fast-paced growth. It is estimated to reach "$28.67 billion in 2029, expanding at a compound annual growth rate (CAGR) of 14.2%. The surge anticipated in the forecast period may be ascribed to factors such as ethical and societal considerations, trends in funding and investment, the demand of patients/consumers, advancements in healthcare infrastructure, and swift cycles of innovation. The forecast period will also see prominent trends like personalized medicine, the growth of specific treatments, advancements in gene editing technologies, expansion of stem cell research, progress in immunotherapy, and manipulation of microenvironments.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

What Drivers Are Propelling the Growth of Cell Therapy Market Forward?
The cell therapy market has benefited from the increased incidence of chronic diseases. Chronic disease, defined by the US Centers for Disease Control and Prevention (CDC) as a condition lasting one year or longer that necessitates medical intervention, restricts daily activities, or both, encompasses afflictions such as heart disease, cancer, diabetes, and Parkinson's disease. Spinal cord injuries, type 1 diabetes, Parkinson's disease (PD), heart disease, cancer, and osteoarthritis patients can be helped with stem cells. For example, in July 2024, the Centers for Disease Control and Prevention (CDC), a national public health agency based in the US, released critical updates relating to public health efforts. Heart disease or stroke claims the lives of more than 944,800 Americans each year, representing over one-third of all deaths. In the U.S., cancer is diagnosed in 1.7 million individuals each year, with over 600,000 deaths, ranking it the second leading cause of death. Moreover, over 38 million Americans are diagnosed with diabetes, with an extra 98 million adults being prediabetic, raising their likelihood of getting type 2 diabetes. Diabetes can result in serious complications such as heart disease, kidney failure, and blindness. Obesity, which affects 20% of children and 42% of adults, increases the risk of chronic illnesses like type 2 diabetes, heart disease, and certain cancers. As a result of the rising incidence of chronic diseases, the demand for cell therapies has increased, promoting the expansion of the cell therapy market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

Which Emerging Trends Are Transforming the Cell Therapy Market in 2025?
Major market participants are tactically teaming up and cooperating to broaden their range of products and deepen their reach across various geographies. Ajinomoto Co Inc., a food enterprise originating from Japan, took over Forge Biologics in November 2023 for a sum of $620 million. By means of this purchase, Ajinomoto Co Inc. aspires to strengthen its worldwide proficiency in AAV and plasmid gene therapy production, thereby enriching and solidifying its pre-existing contract development and manufacturing services. Based in the US, Forge Biologics is a biotech firm that concentrates on propelling cell therapy technology used for treating a range of diseases.

What Are the Key Segments in the Cell Therapy Market?
The cell therapy market covered in this report is segmented -

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy
2) By Therapy Type: Allogeneic Therapies, Autologous Therapies
3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:
1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy
2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine
3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy
4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy
5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp

Who Are the Key Players Shaping the Cell Therapy Market's Competitive Landscape?
Major companies operating in the cell therapy market include Celgene Corporation, JCR Pharmaceuticals Co. Ltd., Baxter Healthcare Corporation, Nipro Corp., Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., Arteriocyte Medical Systems Inc., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Tego Science Inc., Athersys Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, AVROBIO Inc., Cellular Biomedicine Group Inc., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Charles River Laboratories International Inc., Lonza Group Ltd., Catalent Inc.

What Geographic Markets Are Powering Growth in the Cell Therapy Market?
North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3393

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Reach Out to Us
Speak With Our Expert:Saumya Sahay,
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267,
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.